NewEdge Advisors’s Caribou Biosciences CRBU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.1K | Hold |
10,400
| – | – | ﹤0.01% | 3102 |
|
|
2025
Q1 | $9.5K | Hold |
10,400
| – | – | ﹤0.01% | 3120 |
|
|
2024
Q4 | $16.5K | Sell |
10,400
-2,000
| -16% | -$3.18K | ﹤0.01% | 2860 |
|
|
2024
Q3 | $24.3K | Buy |
12,400
+700
| +6% | +$1.37K | ﹤0.01% | 2663 |
|
|
2024
Q2 | $19.2K | Buy |
11,700
+3,500
| +43% | +$5.74K | ﹤0.01% | 2638 |
|
|
2024
Q1 | $42.1K | Hold |
8,200
| – | – | ﹤0.01% | 2368 |
|
|
2023
Q4 | $47K | Buy |
8,200
+1,000
| +14% | +$5.73K | ﹤0.01% | 2254 |
|
|
2023
Q3 | $34.4K | Buy |
7,200
+1,000
| +16% | +$4.78K | ﹤0.01% | 2215 |
|
|
2023
Q2 | $26.4K | Buy |
6,200
+1,100
| +22% | +$4.68K | ﹤0.01% | 2298 |
|
|
2023
Q1 | $27.1K | Buy |
5,100
+3,325
| +187% | +$17.7K | ﹤0.01% | 2233 |
|
|
2022
Q4 | $11 | Buy |
+1,775
| New | +$11 | ﹤0.01% | 3690 |
|